{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:47:38Z","timestamp":1787021258066,"version":"build-2736575974"},"reference-count":38,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T00:00:00Z","timestamp":1486166400000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"DOI":"10.1210\/js.2016-1053","type":"journal-article","created":{"date-parts":[[2017,4,2]],"date-time":"2017-04-02T23:38:28Z","timestamp":1491176308000},"page":"127-143","source":"Crossref","is-referenced-by-count":46,"title":["EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis"],"prefix":"10.1210","volume":"1","author":[{"given":"Takako","family":"Araki","sequence":"first","affiliation":[{"name":"Pituitary Center, Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohai","family":"Liu","sequence":"additional","affiliation":[{"name":"Pituitary Center, Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiraku","family":"Kameda","sequence":"additional","affiliation":[{"name":"Pituitary Center, Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Tone","sequence":"additional","affiliation":[{"name":"Research Division of Immunology, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Pituitary Center, Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Tone","sequence":"additional","affiliation":[{"name":"Research Division of Immunology, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Melmed","sequence":"additional","affiliation":[{"name":"Pituitary Center, Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,1,20]]},"reference":[{"issue":"7","key":"2019041122213550900_B1","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing\u2019s syndrome: a consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2019041122213550900_B2","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1210\/jc.2009-1311","article-title":"Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy","volume":"94","author":"Ben-Shlomo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122213550900_B3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2008-1008","article-title":"Treatment of pituitary-dependent Cushing\u2019s disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial","volume":"94","author":"Boscaro","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2019041122213550900_B4","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A 12-month phase 3 study of pasireotide in Cushing\u2019s disease","volume":"366","author":"Colao","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"2019041122213550900_B5","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jc.2014-1622","article-title":"Ketoconazole as an adrenal steroidogenesis inhibitor: effectiveness and risks in the treatment of Cushing\u2019s disease","volume":"99","author":"Newell-Price","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122213550900_B6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-12-0274","article-title":"Etomidate in the management of hypercortisolaemia in Cushing\u2019s syndrome: a review","volume":"167","author":"Preda","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2019041122213550900_B7","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122213550900_B8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11102-015-0692-z","article-title":"Osilodrostat, a potent oral 11\u03b2-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing\u2019s disease","volume":"19","author":"Fleseriu","year":"2016","journal-title":"Pituitary"},{"issue":"6","key":"2019041122213550900_B9","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1210\/endo.130.6.1597149","article-title":"Development of Cushing\u2019s syndrome in corticotropin-releasing factor transgenic mice","volume":"130","author":"Stenzel-Poore","year":"1992","journal-title":"Endocrinology"},{"issue":"15","key":"2019041122213550900_B10","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1101\/gad.10.15.1870","article-title":"Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+\/- mice","volume":"10","author":"Nikitin AYu","year":"1996","journal-title":"Genes Dev"},{"issue":"7","key":"2019041122213550900_B11","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/MCB.25.7.2660-2672.2005","article-title":"Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland","volume":"25","author":"Lazzerini Denchi","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"20","key":"2019041122213550900_B12","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1073\/pnas.1018091108","article-title":"Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor","volume":"108","author":"Liu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019041122213550900_B13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1677\/joe.1.05616","article-title":"Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells","volume":"183","author":"Theodoropoulou","year":"2004","journal-title":"J Endocrinol"},{"issue":"12","key":"2019041122213550900_B14","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"2019041122213550900_B15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"issue":"3","key":"2019041122213550900_B16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","article-title":"Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease","volume":"25","author":"Ma","year":"2015","journal-title":"Cell Res"},{"issue":"11","key":"2019041122213550900_B17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1530\/ERC-16-0206","article-title":"E2F1-mediated human POMC expression in ectopic Cushing\u2019s syndrome","volume":"23","author":"Araki","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"2019041122213550900_B18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0092-8674(01)00282-3","article-title":"A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins","volume":"104","author":"Lamolet","year":"2001","journal-title":"Cell"},{"issue":"15","key":"2019041122213550900_B19","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1073\/pnas.141234898","article-title":"Tbx19, a tissue-selective regulator of POMC gene expression","volume":"98","author":"Liu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2019041122213550900_B20","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1128\/MCB.17.11.6673","article-title":"NeuroD1\/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene","volume":"17","author":"Poulin","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"11","key":"2019041122213550900_B21","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.1128\/MCB.19.11.7549","article-title":"Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation","volume":"19","author":"Maira","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2019041122213550900_B22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1210\/me.2010-0422","article-title":"A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells","volume":"25","author":"Langlais","year":"2011","journal-title":"Mol Endocrinol"},{"issue":"1","key":"2019041122213550900_B23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/en.2014-1627","article-title":"ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice","volume":"156","author":"Liu","year":"2015","journal-title":"Endocrinology"},{"issue":"10","key":"2019041122213550900_B24","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/00000478-200310000-00005","article-title":"Crooke\u2019s cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma","volume":"27","author":"George","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"15","key":"2019041122213550900_B25","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1158\/0008-5472.CAN-08-0121","article-title":"A small-molecule E2F inhibitor blocks growth in a melanoma culture model","volume":"68","author":"Ma","year":"2008","journal-title":"Cancer Res"},{"issue":"5","key":"2019041122213550900_B26","doi-asserted-by":"crossref","first-page":"e96357","DOI":"10.1371\/journal.pone.0096357","article-title":"E2F inhibition synergizes with paclitaxel in lung cancer cell lines","volume":"9","author":"Kurtyka","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"2019041122213550900_B27","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI20401","article-title":"Mechanisms for pituitary tumorigenesis: the plastic pituitary","volume":"112","author":"Melmed","year":"2003","journal-title":"J Clin Invest"},{"issue":"33","key":"2019041122213550900_B28","doi-asserted-by":"crossref","first-page":"24967","DOI":"10.1016\/S0021-9258(19)74558-X","article-title":"Post-translational processing of proopiomelanocortin (POMC) in mouse pituitary melanotroph tumors induced by a POMC-simian virus 40 large T antigen transgene","volume":"268","author":"Low","year":"1993","journal-title":"J Biol Chem"},{"issue":"2","key":"2019041122213550900_B29","first-page":"656","article-title":"Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness","volume":"81","author":"LeRiche","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122213550900_B30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-15-0689","article-title":"The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing\u2019s disease","volume":"174","author":"Hayashi","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"24","key":"2019041122213550900_B31","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1038\/sj.emboj.7601457","article-title":"p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration","volume":"25","author":"Frey","year":"2006","journal-title":"EMBO J"},{"issue":"6","key":"2019041122213550900_B32","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/emboj\/18.6.1559","article-title":"Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases","volume":"18","author":"Wang","year":"1999","journal-title":"EMBO J"},{"issue":"1","key":"2019041122213550900_B33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/onc.2008.354","article-title":"Phosphorylation by p38 MAP kinase is required for E2F1 degradation and keratinocyte differentiation","volume":"28","author":"Ivanova","year":"2009","journal-title":"Oncogene"},{"issue":"2","key":"2019041122213550900_B34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jnci\/djp458","article-title":"E2F1 in melanoma progression and metastasis","volume":"102","author":"Alla","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"26","key":"2019041122213550900_B35","doi-asserted-by":"crossref","first-page":"12146","DOI":"10.1073\/pnas.92.26.12146","article-title":"Regulation of the cyclin E gene by transcription factor E2F1","volume":"92","author":"Ohtani","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019041122213550900_B36","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1210\/jcem.84.10.6066","article-title":"Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors","volume":"84","author":"Lidhar","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2019041122213550900_B37","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/me.2010-0091","article-title":"Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis","volume":"24","author":"Roussel-Gervais","year":"2010","journal-title":"Mol Endocrinol"},{"issue":"7","key":"2019041122213550900_B38","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1128\/MCB.01885-08","article-title":"Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells","volume":"29","author":"Bilodeau","year":"2009","journal-title":"Mol Cell Biol"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/1\/2\/127\/10252310\/js.2016-1053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:12:39Z","timestamp":1658880759000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/1\/2\/127\/2930778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,20]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,1,20]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/js.2016-1053","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2,1]]},"published":{"date-parts":[[2017,1,20]]}}}